All lobbying filings
LANXESS CORPORATION
LANXESS CORPORATION filed a Q3 report for LANXESS CORPORATION on October 15, 2026.
Lobbying for LANXESS CORPORATION
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 15, 2026
Expenses
$100,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Pennsylvania
Government bodies contacted
4
Lobbying activity
2
Modernization of Food and Drug Administration's "generally recognized as safe" (GRAS) framework.
Section 338 tariffs on Canada.